Exelixis, Inc. (EXEL) Ownership
EXEL ownership summary
as of October 18, 2026- Institutions
- 106.9% of shares outstanding
- Insiders
- 1.85% of shares outstanding
- Shares outstanding
- 247.8M
- Float
- 213.6M shares available to trade
- Short interest
- 15.55% 28.2M shares short
- Days to cover
- 12.71 short interest up 6.8% vs prior month
- Institutions 106.89%
- Insiders 1.85%
EXEL top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 11.73% | 29.1M | $1.81B | −1.7M (−5.6%) | June 30, 2026 |
| 2 | Farallon Capital Management, L.L.C. | 5.44% | 13.5M | $838.1M | +357,000 (+2.7%) | June 30, 2026 |
| 3 | Renaissance Technologies Corp | 5.42% | 13.4M | $835.6M | −299,000 (−2.2%) | June 30, 2026 |
| 4 | Vanguard Portfolio Management, LLC | 4.86% | 12.0M | $749.4M | −42,151 (−0.3%) | June 30, 2026 |
| 5 | AQR Capital Management LLC | 4.45% | 11.0M | $686.0M | −2.1M (−15.8%) | June 30, 2026 |
| 6 | Vanguard Capital Management, LLC | 4.42% | 11.0M | $681.5M | −307,987 (−2.7%) | June 30, 2026 |
| 7 | State Street Corp | 4.02% | 10.0M | $620.4M | −328,368 (−3.2%) | June 30, 2026 |
| 8 | Fuller & Thaler Asset Management Inc | 3.60% | 8.9M | $555.7M | +387,153 (+4.5%) | June 30, 2026 |
| 9 | LSV Asset Management | 3.29% | 8.1M | $507.0M | +400,763 (+5.2%) | June 30, 2026 |
| 10 | Geode Capital Management, LLC | 3.09% | 7.7M | $476.1M | −145,294 (−1.9%) | June 30, 2026 |
| 11 | D. E. Shaw & Co LP | 2.24% | 5.6M | $345.5M | +1.9M (+54.1%) | June 30, 2026 |
| 12 | Morgan Stanley - Brokerage Accounts | 1.82% | 4.5M | $281.3M | +341,448 (+8.2%) | June 30, 2026 |
| 13 | Amvescap Plc. | 1.81% | 4.5M | $279.8M | +181,316 (+4.2%) | June 30, 2026 |
| 14 | Dimensional Fund Advisors, Inc. | 1.79% | 4.4M | $275.5M | +127,023 (+3.0%) | June 30, 2026 |
| 15 | Arrowstreet Capital Limited Partnership | 1.76% | 4.4M | $271.7M | −468,699 (−9.7%) | June 30, 2026 |
| 16 | Two Sigma Investments LLC | 1.70% | 4.2M | $262.0M | +2.0M (+90.8%) | June 30, 2026 |
| 17 | Genworth Financial Wealth Mgmt Inc | 1.39% | 3.4M | $213.7M | +44,904 (+1.3%) | June 30, 2026 |
| 18 | Nuveen, LLC | 1.32% | 3.3M | $203.9M | −505,750 (−13.4%) | June 30, 2026 |
| 19 | UBS Group AG | 1.28% | 3.2M | $197.1M | +774,377 (+32.4%) | June 30, 2026 |
| 20 | Los Angeles Capital Management LLC | 1.25% | 3.1M | $193.1M | +2.0M (+174.3%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 11 holders added 8.5M shares and 9 cut 5.9M.
EXEL top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | iShares Core S&P Mid-Cap ETF | 3.56% | 8.8M | $549.2M | −3,156 (−0.0%) | September 30, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 3.07% | 7.6M | $472.8M | −8,574 (−0.1%) | August 31, 2026 |
| 3 | FullerThaler Behavioral Sm-Cp Eq R6 | 2.84% | 7.0M | $438.2M | −48,600 (−0.7%) | June 30, 2026 |
| 4 | Vanguard Small Cap Index | 2.14% | 5.3M | $329.7M | −195,577 (−3.6%) | September 30, 2026 |
| 5 | Invesco S&P MidCap Quality ETF | 1.25% | 3.1M | $192.2M | +3,225 (+0.1%) | September 30, 2026 |
| 6 | Vanguard MStar Small Cap Growth Indx Inv | 1.19% | 2.9M | $183.4M | −206,170 (−6.5%) | September 30, 2026 |
| 7 | State Street® SPDR® S&P® Biotech ETF | 1.03% | 2.5M | $158.7M | −48,550 (−1.9%) | September 30, 2026 |
| 8 | iShares Biotechnology ETF | 0.76% | 1.9M | $116.5M | −14,176 (−0.8%) | September 30, 2026 |
| 9 | State Street® SPDR® S&P MIDCAP 400® ETF | 0.74% | 1.8M | $114.0M | −6,111 (−0.3%) | September 30, 2026 |
| 10 | First Trust NYSE Arca Biotech ETF | 0.65% | 1.6M | $99.7M | — | September 30, 2026 |
| 11 | Vanguard Explorer Inv | 0.63% | 1.6M | $97.9M | — | June 30, 2026 |
| 12 | iShares S&P Mid-Cap 400 Growth ETF | 0.58% | 1.4M | $89.0M | −1,526 (−0.1%) | September 30, 2026 |
| 13 | Strategic Advisers U.S. Total Stock | 0.55% | 1.4M | $84.3M | −10,201 (−0.7%) | August 31, 2026 |
| 14 | State Street SPDR Port S&P 400 Md CpETF | 0.53% | 1.3M | $81.5M | −1,840 (−0.1%) | September 30, 2026 |
| 15 | Fidelity Extended Market Index | 0.49% | 1.2M | $76.1M | −14,929 (−1.2%) | August 31, 2026 |
| 16 | Avantis US Large Cap Value ETF | 0.47% | 1.2M | $72.7M | +3,472 (+0.3%) | September 30, 2026 |
| 17 | Strategic Advisers Fidelity US TtlStk | 0.45% | 1.1M | $69.1M | +10,040 (+0.9%) | August 31, 2026 |
| 18 | iShares Russell Mid-Cap ETF | 0.41% | 1.0M | $63.9M | +1,900 (+0.2%) | September 30, 2026 |
| 19 | FullerThaler Behvrll Uncnstd Eq R6 | 0.41% | 1.0M | $63.0M | +158,600 (+18.6%) | August 31, 2026 |
| 20 | Fidelity Mid Cap Index | 0.38% | 949K | $59.0M | +4,084 (+0.4%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
EXEL insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-24 | Dana Aftab | Sell | $44.50 | 47,918 | $2.1M |
| 2026-02-19 | Dana Aftab | Sell | $44.35 | 29,873 | $1.3M |
| 2026-02-18 | Brenda Hefti | Sell | $44.01 | 18,669 | $821,623 |
| 2026-02-18 | Jack L Wyszomierski | Sell | $44.01 | 99,574 | $4.4M |
| 2026-02-17 | Christopher J Senner | Sell | $43.67 | 30,617 | $1.3M |
| 2026-02-17 | Patrick J Haley | Sell | $43.52 | 67,814 | $3.0M |
| 2026-02-13 | Bob Oliver | Sell | $43.81 | 30,250 | $1.3M |
| 2026-02-13 | Christopher J Senner | Sell | $43.00 | 34,278 | $1.5M |
| 2026-02-13 | Sue Gail Eckhardt | Sell | $43.79 | 3,856 | $168,854 |
| 2025-11-21 | Patrick J Haley | Sell | $42.58 | 28,043 | $1.2M |
| 2025-11-20 | Patrick J Haley | Sell | $42.11 | 10,000 | $421,100 |
| 2025-11-20 | Patrick J Haley | Sell | $41.88 | 34,187 | $1.4M |
| 2025-11-12 | Stelios Papadopoulos | Sell | $43.55 | 100,000 | $4.4M |
| 2025-11-11 | Dana Aftab | Sell | $42.50 | 48,383 | $2.1M |
| 2025-11-11 | Mary C Beckerle | Sell | $41.93 | 24,622 | $1.0M |
| 2025-06-03 | Jack L Wyszomierski | Sell | $43.09 | 7,535 | $324,683 |
| 2025-06-02 | Sue Gail Eckhardt | Sell | $42.74 | 18,838 | $805,136 |
| 2025-05-21 | Tomas J Heyman | Sell | $44.29 | 4,544 | $201,254 |
| 2025-05-20 | Patrick J Haley | Sell | $44.06 | 34,387 | $1.5M |
| 2025-05-16 | Amy C Peterson | Sell | $45.47 | 72,776 | $3.3M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
EXEL shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns EXEL
Institutional investors own 106.9% of Exelixis's shares and insiders 1.85%. The largest holder is BlackRock Inc with 11.73% of the shares (29.1M), as of June 30, 2026. Among the top 20 institutions, 11 added shares and 9 reduced their stake in the latest filings. Short interest is 15.55% of the float, or 12.71 days of average trading volume. The share count rose 44.1% since 2014.
Related: EXEL analyst forecast, EXEL key metrics. See the EXEL stock overview for the latest quote and news.
EXEL ownership FAQ
Who owns the most Exelixis stock?
The largest shareholders of Exelixis are BlackRock Inc (11.73%), Farallon Capital Management, L.L.C. (5.44%), Renaissance Technologies Corp (5.42%), Vanguard Portfolio Management, LLC (4.86%), AQR Capital Management LLC (4.45%).
What percentage of Exelixis is owned by institutions?
Institutions hold 106.9% of Exelixis's shares outstanding; insiders hold 1.85%.
Which funds own Exelixis?
The largest fund holders of Exelixis are iShares Core S&P Mid-Cap ETF (3.56%), Vanguard MStar Total Stk Mkt Idx Invest (3.07%), FullerThaler Behavioral Sm-Cp Eq R6 (2.84%), Vanguard Small Cap Index (2.14%), Invesco S&P MidCap Quality ETF (1.25%).
What is Exelixis's short interest?
28.2M shares of Exelixis were sold short, 15.55% of the float; at the average daily volume it would take 12.71 days to cover.
Are insiders buying or selling Exelixis?
Of the latest 20 reported insider transactions in Exelixis (since May 16, 2025), 0 were purchases and 20 were sales.
How many shares of Exelixis are outstanding?
Exelixis has 247.8M shares outstanding, of which 213.6M are in the public float.